Substance Name: Aducanumab [USAN:INN]
RN: 1384260-65-4
UNII: 105J35OE21
Note
- MAB against Amyloid beta-Peptide for treatment of Alzheimer Disease.
Molecular Formula
- C6472-H10028-N1740-O2014-S46
Classification Code
- Treatment of Alzheimer's Disease
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Aducanumab [USAN:INN]
Synonyms
- Aducanumab
- BIIB 037
- BIIB-037
- BIIB037
- Immunoglobulin G1-kappa, anti-(human amyloid beta A4 protein(ABPP, APPI, Alzheimer disease amyloid protein, cerebral vascular amyloid peptide, protease nexin-II)), Homo sapiens monoclonal antibody; gamma 1 heavy chain (1-453) (Homo sapiens VH (IGHV3-33*01 Q1>pyroGlu(1) (93.9%)-(IGHD)-IGHJ6*03) (8.8.17) (1-124)-IGHG1*03 des-CH3K107 (125-453)), (227-214')-disulfide with kappa light chain (1'-214') (Homo sapiens V-KAPPA (IGKV1D-39*01 (100%)-IGKJ4*01) (6.3.9) (1'-107')-IGKC*01 (108'-214')); dimer (233-233'':236-236'')-bisdisulfide
- UNII-105J35OE21
Systematic Name
- Immunoglobulin G1, anti-(human beta-amyloid) (human monoclonal BIIB037 heavy chain), disulfide with human monoclonal BIIB037 kappa-chain, dimer
Registry Numbers
CAS Registry Number
- 1384260-65-4
FDA UNII
- 105J35OE21
System Generated Number
- 1384260654